Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nonmalignant Diseases”

178 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 178 results

Not applicableEnded earlyNCT04008849
What this trial is testing

A Follow-up Study in Patients With Inherited Metabolic Disorders (IMD) Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) With MGTA-456

Who this might be right for
Inherited Metabolic Disorders (IMD)
Magenta Therapeutics, Inc. 3
Not applicableStudy completedNCT03781661
What this trial is testing

Providing Patient Information and CT Examination Results

Who this might be right for
Chest PainNonmalignant Condition
Haukeland University Hospital 92
Not applicableLooking for participantsNCT01166009
What this trial is testing

CIBMTR Research Database

Who this might be right for
Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more
Center for International Blood and Marrow Transplant Research 99,999,999
Testing effectiveness (Phase 2)Study completedNCT02490436
What this trial is testing

Novel Treatment Option for Neuropathic Pain

Who this might be right for
NeuralgiaComplex Regional Pain Syndromes
Sorlandet Hospital HF 15
Not applicableStudy completedNCT00574392
What this trial is testing

Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo

Who this might be right for
Basal Cell CarcinomaMelanomaNon-Malignant Skin Disorders+1 more
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03924401
What this trial is testing

Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant

Who this might be right for
Graft Versus Host Disease
Emory University 30
Large-scale testing (Phase 3)Study completedNCT00487435
What this trial is testing

An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain

Who this might be right for
PainOsteoarthritisLow Back Pain
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,166
Testing effectiveness (Phase 2)Study completedNCT01810120
What this trial is testing

Trial to Assess the Efficacy of a TCR Alfa Beta Depleted Graft in Pediatric Affected by ALL or AML and Receiving an HSCT

Who this might be right for
Acute Lymphoblastic LeukemiaLeukemia Acute Myeloid - AMLNon-Hodgkin Lymphoma+1 more
Mariella Enoc 30
Not applicableUnknownNCT01665495
What this trial is testing

Drainage or Pericardiocentesis (DROP) Alone for Recurrent Non-malignant Pericardial Effusions Requiring Intervention

Who this might be right for
Pericardial Effusion
Maria Vittoria Hospital 122
Testing effectiveness (Phase 2)WithdrawnNCT00816413
What this trial is testing

Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of Nebraska
Not applicableActive Not RecruitingNCT05236764
What this trial is testing

Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion

Who this might be right for
Acute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionMyelodysplastic Syndromes+8 more
Baylor College of Medicine 3
Not applicableStudy completedNCT01873573
What this trial is testing

Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone Injection

Who this might be right for
Dysphagia
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)WithdrawnNCT05288595
What this trial is testing

TCR Alpha/Beta and CD19-deplete Haplo-HSCT

Who this might be right for
Pediatric PatientsHematologic MalignancyOther Hematologic Condition
University of Colorado, Denver
Testing effectiveness (Phase 2)Study completedNCT00003336
What this trial is testing

Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)WithdrawnNCT01206907
What this trial is testing

Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects

Who this might be right for
Chronic Pain
Endo USA Inc., a Keenova Therapeutics Company
Testing effectiveness (Phase 2)Study completedNCT00005804
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
Fred Hutchinson Cancer Center
Not applicableUnknownNCT05494099
What this trial is testing

Extended Endoscopic Approaches to Non-malignant Maxillary Sinus Lesions Comparative

Who this might be right for
Maxillary Sinus DiseaseApproach-Approach Conflict
Tanta University 75
Large-scale testing (Phase 3)Study completedNCT00261495
What this trial is testing

The Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

Who this might be right for
Pain
Janssen Pharmaceutica N.V., Belgium 504
Post-approval studies (Phase 4)Study completedNCT01961271
What this trial is testing

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Who this might be right for
OsteoarthritisRheumatoid ArthritisLower Back Pain+2 more
Mundipharma Pte Ltd. 114
Testing effectiveness (Phase 2)Looking for participantsNCT03128996
What this trial is testing

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Who this might be right for
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3 more
Washington University School of Medicine 29
Load More Results